Tenere Capital LLC Zoetis Inc. Transaction History

Tenere Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $2.85 Million - $3.3 Million	17,700 New	17,700 $3.05 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $2.83 Million - $3.4 Million	-21,600 Reduced 27.17%	57,900 $8.49 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $1.69 Million - $2.08 Million	11,400 Added 16.74%	79,500 $11.8 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $4.27 Million - $5.48 Million	27,400 Added 67.32%	68,100 $11.7 Million
Q1 2022 May 17, 2022	BUY	$181.39 - $234.03 $2.74 Million - $3.53 Million	15,100 Added 58.98%	40,700 $7.68 Million
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $4.64 Million - $5.99 Million	25,600 New	25,600 $3.94 Billion

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Tenere Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Tenere Capital LLC with notifications on news.